Video Creative
ADMP Historical Stock Prices ยป
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adamis Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy. Co. is developing several products in the allergy and respiratory markets, including its Epinephrine Injection pre-filled syringe (PFS), product for use in the emergency treatment of acute allergic reactions, including anaphylaxis; albuterol (APC-2000) and fluticasone (APC-4000) dry powder inhaler (DPI), products for the treatment of bronchospasm and asthma, respectively; and beclomethasone (APC-1000), a metered dose inhaler product for the treatment of asthma. According to our ADMP split history records, Adamis Pharmaceuticals has had 1 split.
ADMP split history picture
Adamis Pharmaceuticals (ADMP) has 1 split in our ADMP split history database. The split for ADMP took place on December 13, 2013. This was a 1 for 17 reverse split, meaning for each 17 shares of ADMP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 58.8235294117647 share position following the split.

When a company such as Adamis Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ADMP split history from start to finish, an original position size of 1000 shares would have turned into 58.8235294117647 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adamis Pharmaceuticals shares, starting with a $10,000 purchase of ADMP, presented on a split-history-adjusted basis factoring in the complete ADMP split history. ADMP split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/23/2008
End date: 01/22/2018
Start price/share: $0.85
End price/share: $4.15
Dividends collected/share: $0.00
Total return: 388.24%
Average Annual Total Return: 17.17%
Starting investment: $10,000.00
Ending investment: $48,813.66
Years: 10.01
Date Ratio
12/13/20131 for 17
ADMP is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ADMS Split History
ADPT Split History
ADXS Split History
AEZS Split History
AFAM Split History
AFFX Split History
AGN Split History
AHPI Split History
AIMT Split History
AIQ Split History

More latest

ADMP Insider Buying